Tags: MDMAecstasyPTSD therapyhumourpharma
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | Illuccix therapy gets approval in the UK - 10 days ago | |
| 2 | Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. | ||
| 3 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
| 4 | Brian T. Horowitz InformationWeek Writer on enterprise IT, AI, IoT. New York | What to Prioritize in Health IT in 2025 - 2 months ago | |
| 5 | Elise Reuter MedTech Dive Reporter @MedTechDive. Covers medical devices. | ||
| 6 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Novel Prostate Cancer Screening Method Could Prevent Unnecessary Biopsies - about 1 year ago KEYNOTE-A18 Data Are 'Practice-Changing' for Cervical Cancer - about 1 year ago Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer - about 1 year ago Experts' Hopes for the Future of dMMR Uterine Cancer Treatment - about 1 year ago | |
| 7 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | 2024 PharmaVoice 100s: Tech and AI Wizards - 4 months ago | |
| 8 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | ||
| 9 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | Advancing qPCR Through Innovation - 7 months ago | |
| 10 | Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. |